Ophthalmology Clinical Trials
The University of Virginia Department of Ophthalmology faculty members conduct their own research to investigate new treatment options for ophthalmic diseases and conditions. The department is actively involved in many industry-sponsored clinical trials to test new ophthalmic procedures and treatments. In recent years, the department has participated in clinical trials to investigate new treatments for diabetic macular edema, geographic atrophy, and neovascular age-related macular degeneration.
For more information or to participate in one of our trials, please contact:
Clinical Research Manager: Ashton Leone, MPH, CCRP, CCRA
Clinical Research Coordinator: Maria Isabel Curioso
Clinical Research Coordinator: Lacey Morris
Current Clinical Trials
Apricity-A Study—A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-Linking in Subjects 8 to 45 Years of Age with Keratoconus (Apricity-A)
Sponsor: Epion Therapeutics, Inc.; Principal Investigator: Tara McGehee, MD
LOTUS Study—Leveraging Ocular Tissues in Uveitis Study
Sponsor: University of California at San Francisco; Principal Investigator: Arthi Venkat, MD
Tarsier-04 Study—A Phase 3 Randomized, Active-Controlled, Double-Masked Study to Evaluate the Safety and Efficacy of TRS01 Eye Drops in the Treatment of Subjects with Active Non-infectious Anterior Uveitis including Subjects with Uveitic Glaucoma
Sponsor: Tarsier Pharma Ltd.; Principal Investigator: Arthi Venkat, MD